Clinical Trials & Research
Intralytix is dedicated to advancing human health through rigorous clinical research. Explore our ongoing and completed FDA-approved clinical trials below.
EcoActive™
Target: Targeting adherent-invasive E. coli (AIEC) in Crohn's disease
Baltimore Metro Area, MD
Trial DetailsNew York, NY
Trial DetailsShigActive™
Target: Targeting Shigella, the causative agent of dysentery
Baltimore, MD
Trial DetailsVRELysin™
Target: Targeting vancomycin-resistant Enterococci in the gut
Pittsburgh, PA
Trial Details Back to Home
Scientific Integrity
"All Intralytix clinical trials are conducted in accordance with GCP standards and FDA oversight."